Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L36 pseudogene 2 (RPL36P2, also known as dJ530I15.5) is a human pseudogene related to the RPL36 gene, which normally encodes a component of the 60S ribosomal subunit involved in protein synthesis. Unlike the functional RPL36 gene, RPL36P2 lacks catalytic or binding activity, does not encode a functional protein, and is not implicated as a therapeutic target or biomarker. It is one of several processed pseudogenes of RPL36, reflecting genome duplication events, and has no known biological or disease role[6][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L36 pseudogene 2 (RPL36P2).